Biosfer Teslab in the 8th National Cardiovascular Meeting of SEMERGEN
On the 21th of May, Biosfer Teslab took part in the 8th Cardiovascular Meeting of SEMERGEN, in Santander. Nuria Amigó took part in a session which name was “The significance of the size of lipoproteins in cardiovascular risk filtering. More information here.
The Di@bet.es 2 study will define risk scales that will let us apply prevention programs for less people, but better targeted
The Research Program of CIBERDEM is focused on the study of the epidemiology of diabetes mellitus; genetics, epigenetics and related environmental factors with this pathology, and the associated molecular mechanisms to the onset and progress of the cronical complications of the diabetes. In addition, in the framework of this program, there are other nutritional issues […]
Prize-giving for young talents
Biosfer Teslab was awarded with one of the Premis Gresol for Young talents in front of 250 people at Flash Back room, Salou, from the Gresol Fundation. These prizes reclaim the talent of entrepreneurs and professionals from the regions of Camp de Tarragona and reinforce the values of the business world. More information here.
Biosfer Teslab to Boston
Biosfer to Boston, one of the 20 finalists projects of the international startups acceleration program, The Big Booster More information here.
Biosfer Teslab in the newspaper la Vanguardia
News about Biosfer Teslab appeared in the reportage of the la Vanguardia newspaper, 25 of October, 2015, it’s title was “Un test més efectiu per al ‘colesterol dolent’” that means “A more efective test for the ‘bad cholesterol’” More information here.
Open call to join our operations team
Biosfer Teslab, an in vitro diagnostic company that develops novel NMR-based tests to improve cardiovascular risk assessment in patients at high cardio-metabolic risk, is looking for candidates to join our operations team. The company arises from the research carried out at the Metabolomics Platform and the Lipids and Atherosclerosis Research Unit from the Rovira i […]
Open call for an Industrial Doctorate
Biosfer Teslab, an in vitro diagnostic company that develops novel NMR-based tests to improve cardiovascular risk assessment in patients at high cardio-metabolic risk, is looking for Industrial Doctorate candidates. The company arises from the research carried out at the Metabolomics Platform and the Lipids and Atherosclerosis Research Unit from the Rovira i Virgili University and […]
Practical Applications of NMR in Industry Conference (PANIC) – Feb 2015 La Jolla, CA
Roger Mallol will give a talk in the 3rd Annual Practical Applications of NMR in Industry Conference (PANIC) that will take place in La Jolla, CA, February 9-12, 2015. PANIC was initiated to provide an interactive forum for discussion of the latest developments in the use of NMR for practical applications to real problems faced […]
Call for an Industrial Doctoral Student
Biosfer Teslab is seeking candidates for an industrial doctorate to develop NMR-based in vitro diagnostic tests for cardiovascular risk assessment.
Biosfer Teslab will attend the “Atherosclerosis and Cardio-Endocrine Biomarkers” course
Biosfer Teslab will attend the “Atherosclerosis and Cardio-Endocrine Biomarkers” course to be held on 25th – 27th of September in Bruges and Mons, Belgium. The course is supported by The Belgian Atherosclerosis Society / Lipid Club (BAS / BLC) and the Royal Belgian Society of Clinical Chemistry (RBSCC). Further information about the program here.
